Characteristic | Training cohort (n = 95) | Validation cohort (n = 41) | Estimate risk* | p value | ||
---|---|---|---|---|---|---|
Non-conspicuous (n = 21) | Conspicuous (n = 74) | Non-conspicuous (n = 9) | Conspicuous (n = 32) | |||
Age, mean ± SD, years | 56.3 ± 14.7 | 60.4 ± 12.4 | 54.7 ± 14 | 52.5 ± 12.5 | ||
Gender, n (%) | ||||||
Male | 9 (42.8) | 45 (60.8) | 6 (66.7) | 26 (81.2) | 1 | 0.144 |
Female | 12 (57.2) | 29 (39.2) | 3 (33.3) | 6 (18.8) | 0.48 (0.18,1.29) | |
Etiology, n (%) | ||||||
Post-hepatic cirrhosis | 12 (57.1) | 4 (44.4) | 48 (64.9) | 18 (56.2) | / | 0.998 |
Alcoholic cirrhosis | 6 (28.6) | 4 (44.4) | 14 (18.9) | 10 (31.2) | / | |
Combined cirrhosis | 1 (4.8) | 0 (0) | 2 (2.8) | 2 (6.3) | / | |
Primary biliary cirrhosis | 2 (9.5) | 1 (11.2) | 8 (10.8) | 2 (6.3) | / | |
Autoimmune hepatic cirrhosis | 0 (0) | 0 (0) | 1 (1.3) | 0 (0) | ||
Cryptogenic cirrhosis | 0 (0) | 0 (0) | 1 (1.3) | 0 (0) | ||
Child–Pugh class, n (%) | ||||||
Class A | 8 (38.1) | 3 (33.3) | 18 (24.3) | 9 (28.1) | 1 | 0.195 |
Class B | 8 (38.1) | 2 (22.2) | 38 (51.4) | 15 (46.9) | 2.11 (0.68–6.53) | |
Class C | 5 (23.8) | 4 (44.5) | 18 (24.3) | 8 (25) | 1.6 (0.44–5.84) |